J. Matsui
23 Papers
1 Citations
J. Matsui is an academic researcher. The author has contributed to research in topics: Medicine & Radiation therapy. The author has an hindex of 4, co-authored 19 publications.
Chat about Author
Papers
68Ga-DOTATATE PET-based Radiation Contouring Creates More Precise Radiation Volumes for Meningioma Patients.
H. Perlow,Michael Siedow,Yevgeniya Gokun,Joseph P. McElroy,J. Matsui,Wesley Zoller,Sasha Beyer,Andrea L. Arnett,Dukagjin Blakaj,Daniel J. Boulter,Joel Fritz,Eric D. Miller,Raju R. Raval,C. Kleefisch,Joseph Bovi,Joshua D. Palmer +15 more
TL;DR: In this article , the authors evaluated retrospective, deidentified, and blinded gross tumor volume contour delineation with 7 central nervous system (CNS) specialists (4 CNS radiation oncologists and 3 neuroradiologists) for 25 patients with a meningioma diagnosis who received both a 68Ga-DOTATATE PET and an MRI for radiation treatment planning.
24
Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysis
Joshua D. Palmer,H. Perlow,J. Matsui,C. Ho,Rahul N. Prasad,Kevin Liu,R. C. Upadhyay,Brett Klamer,Joshua L. Wang,Mark Damante,Jayeeta Ghose,Dukagjin Blakaj,Sasha Beyer,John C. Grecula,Andrea L. Arnett,Evan M. Thomas,Arnab Chakravarti,Russell R. Lonser,Douglas A. Hardesty,Daniel M. Prevedello,Roshan S. Prabhu,James B. Elder,Raju R. Raval +22 more
TL;DR: It is hypothesized that pre-operative fractionated stereotactic radiation therapy (FSRT) can minimize rates of LF, RN, and MD and appears to be safe, effective, and may decrease the incidence of adverse outcomes.
21
Dose-escalated accelerated hypofractionation for elderly or frail patients with a newly diagnosed glioblastoma
H. Perlow,Alexander Yaney,Michael Yang,Brett Klamer,J. Matsui,Raju R. Raval,Dukagjin Blakaj,Andrea L. Arnett,Sasha Beyer,James B. Elder,Mario Ammirati,Russell R. Lonser,Douglas A. Hardesty,Shirley Ong,Pierre Giglio,Clement Pillainayagam,J. Goranovich,John C. Grecula,Arnab Chakravarti,Vinai Gondi,D. D. Brown,Joshua D. Palmer +21 more
TL;DR: Isoeffective dosing to 52.5 Gy in 15 fractions was associated with superior OS compared to standard of care 40 Gy with temozolomide, and hypothesis generating data support accelerated hypofractionation in future prospective trials.
12
Comparing pre-operative versus post-operative single and multi-fraction stereotactic radiotherapy for patients with resectable brain metastases
H. Perlow,C. Ho,J. Matsui,Rahul N. Prasad,Brett Klamer,Joshua L. Wang,Mark Damante,R. C. Upadhyay,Evan Thomas,Dukagjin Blakaj,Sasha Beyer,Russell R. Lonser,Douglas A. Hardesty,Raju R. Raval,Roshan S. Prabhu,James B. Elder,Joshua D. Palmer +16 more
TL;DR: In this article , the authors hypothesize that pre-operative fractionated stereotactic radiation therapy (FSRT) will have less toxicity compared to patients who receive post-operative SRS or FSRT.
12
Risk Factors for Progression and Toxic Effects After Preoperative Stereotactic Radiosurgery for Patients With Resected Brain Metastases.
Roshan S. Prabhu,T. Akinyelu,Zachary K. Vaslow,J. Matsui,Neda Haghighi,Tu Dan,Mark V. Mishra,Erin S. Murphy,S. Boyles,H. Perlow,Joshua D. Palmer,C. Udovicich,Toral R. Patel,Zabi Wardak,Graeme F. Woodworth,Alexander Ksendzovsky,Kailin Yang,Samuel T. Chao,Anthony L. Asher,Stuart H. Burri +19 more
TL;DR: In this paper , the authors evaluated preoperative stereotactic radiosurgery (SRS) outcomes and prognostic factors from a large international multicenter cohort (Preoperative Radiosurgery for Brain Metastases-PROPS-BM).
11